LMAT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
LMAT is not a good buy right now for a Beginner-focused, long-term investor with $50,000-$100,000 available, especially given the current pre-market price near 99.58 and the lack of a strong immediate catalyst. The stock has solid long-term analyst support and upbeat price target revisions, but the current technical setup and options sentiment do not support an aggressive buy at this moment. For an impatient investor, the better call is to hold and wait for a clearer trend or stronger entry confirmation.
The technical picture is mixed to weak. MACD histogram is -0.647 and still below zero, showing downside momentum, though it is negatively contracting, which suggests selling pressure may be easing. RSI_6 at 36.342 is neutral-to-weak, not yet oversold enough to signal an attractive immediate bounce. Moving averages are converging, which typically reflects consolidation rather than a confirmed uptrend. Price is currently below the pivot level of 101.893, with support at 96.442 and resistance at 107.344. Short-term pattern analysis also points to weakness, with an estimated -4.99% move over the next week and -10.98% over the next month.
["Analysts remain constructive overall, with multiple Buy/Outperform ratings.", "Price targets were recently raised, including Lake Street to 135, Citizens to 127, and Barrington to 120.", "Analysts cited a clean Q1, strong execution, improved FY26 margin and EPS expectations, and confidence in pricing strategy and international expansion."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "Hedge funds are selling, and the selling increased 398.42% over the last quarter.", "Options sentiment is bearish with a high put-call open interest ratio of 3.82.", "Technical momentum is weak, with MACD below zero and price below the pivot level.", "Pattern-based trend outlook suggests downside over the next week and month."]
No usable financial snapshot was provided due to an error, so the latest quarter financials cannot be directly assessed. However, analyst commentary indicates the company had a clean Q1 and is tracking toward or above its 12% mid-point growth guidance. The latest referenced quarter appears to be Q1 2026, and commentary suggests continued double-digit organic growth, operating leverage, and margin expansion.
Wall Street remains broadly positive. Recent analyst actions in May 2026 included multiple price target increases and maintained Buy/Outperform ratings: Lake Street to 135 with Buy, Barrington to 120 with Outperform, and Citizens to 127 with Outperform. Earlier in March, Freedom Capital initiated at Hold with a 113 target, creating a mildly mixed but still mostly constructive picture. Overall, the pros see strong execution, pricing power, international expansion, and margin expansion as positives, while the main con is concern that price increases may moderate in later years.
